7:00 – 8:00 am Registration, Continental Breakfast and Exhibitor Set-Up

8:00 – 9:00 am Legal Liability Driven Suicide Prevention in Jails and Prisons
Suicide is the number one cause of death in US jails and the third cause in prisons. The legal ramifications, emotional and financial consequences of these deaths are staggering. Millions of dollars are paid out to the survivors. How can these deaths be prevented and avoid lawsuits? Procedures and practices based on court decisions provide a preferred approach for prevention. This highly informative and inspiring talk pulls from extensive clinical experience and research on suicide in correctional settings.
OBJECTIVES
1. Identify ten risk factors to minimize suicide and Improve outcome.
2. Learn five ways on how to be the eyes and ears of suicide prevention.
3. Discover how to navigate policies, procedures and practices to prevent suicides and avoid lawsuits.
Anasseril E. Daniel, MD, Daniel Forensic Psychiatric Services

9:00 – 10:00 am The General Psychiatrist and Tourette
Tourette Disorder onsets in childhood and is typically thought of as a pediatric disorder that does not involve psychiatric care as adults. However, with over 80% of patients with Tourette having a psychiatric co-morbid diagnosis and at least 50% of those psychiatric problems persisting into adulthood, general psychiatrists would benefit from understanding this disorder more thoroughly. This presentation will focus on the psychiatric co-morbidities and treatment differences observed in Tourette patients in response to treatment.
OBJECTIVES
1. Audience members will increase their knowledge of the psychiatric problems faced by patients with Tourette Disorder.
2. Audience members will learn about treatment alternatives for the psychiatric problems in Tourette patients.
3. Audience members will be able to identify at least two differences in treatment responses in patients with Tourette Disorder compared to patients with similar psychiatric problems without the presence of Tourette.
James R. (Bob) Batterson, MD, DLFAPA, Children’s Mercy Hospital

10:00 – 10:30 am Break with Exhibitors

10:30 – 11:30 am Evolving Controversies in Treating Gender Dysphoric Youth (virtual)
The treatment of children and adolescents diagnosed with Gender Dysphoria (DSM-5-TR) or Gender Incongruence (ICD-11) has evoked both clinical and social controversies. This presentation begins by defining some terms specific to this patient population. It then review both clinical and social controversies surrounding diagnosing and treating minors with GD/GI. Recent political, legislative and judicial events surrounding the treatment of transgender minors are discussed.
OBJECTIVES
1. Identify three current, differing treatment approaches for prepubescent children with Gender Dysphoria in Childhood.
2. Describe the controversies in the wider culture regarding the treatment of gender dysphoric children and adolescents and how they affect clinical practice and research.
3. Prepare for appropriate treatments, consultations and referrals of children and adolescents with Gender Dysphoria.
4. Critique and revise binary thinking about gender and gender identity.
5. Compare diagnostic criteria of the DSM-5-TR gender diagnoses with those of ICD-11.
Jack Drescher, MD, Clinical Professor of Psychiatry, Columbia University, Adjunct Professor, New York University, Training and Supervising Analyst, W.A. White Institute

11:30 – 12:30 pm Lunch with Exhibitors

12:30 – 1:30 pm Climate Distress and Reasonable Hope (virtual)
Climate change is the number one public health concern of the twenty-first century, with one billion youth <18-years-old at “extremely high risk” of climate change-related health effects, particularly in communities of color and low-income settings. 69% of adults and 84% of youth report being at least moderately worried about climate change. 45% of young people report these worries are so severe as to negatively impact their daily life and functioning. The emerging phenomenon in which individuals feel anger, depression, anxiety and other emotions about climate change has come to be known broadly as climate distress. There is a critical need to understand how climate distress affects people clinically, identify who is most vulnerable, and formulate ways to promote resiliency and wellbeing. This talk will summarize what is known about climate distress and summarize preliminary data on how to foster reasonable hope in the face of this global crisis.
OBJECTIVES
1. Define climate anxiety/distress and related climate emotion syndromes.
2. Describe who has climate distress and why.
3. Describe considerations for how to address climate distress clinically. Joshua Wortzel, MD, Brown University, Climate Change and Mental Health Committee, APA

1:30 – 1:45 pm Break with Exhibitors

1:45 – 2:45 pm Can You See Us? The Erasure & Invisibility of Black Girls & Women
Historically, Black women and girls have been erased and deemed invisible. Whether that’s in the workplace, the school house, within their homes, or even on the sidewalk walking down the street. Their experiences and accomplishments have been taken credit for, ignored, and dismissed. Knowing this,
how do we better serve this population? How do we uplift? How do we establish a secure enough environment where our Black women and girls feel valued and seen? This presentation will explore the history of Black women and girls in relation to erasure and invisibility and then further discuss how that impacts organizational culture which then leads to impacting clinical care.
OBJECTIVES
1. Defining and differentiating erasure and invisibility
2. To identify organizational workplace contributions and the role in erasure and invisibility
3. Prioritizing staff wellness and mental health in order to provide the best patient care
4. To learn experiences, terms, and paradigms specific to Black women and girls
Taylor Bass, LMSW, CD, Washington University School of Medicine Perinatal Behavioral Health Service

2:45 – 3:45 pm Gender Dysphoria and Affirming Treatments: What a Mental Health Clinician Needs to Know (virtual)
OBJECTIVES
1. Gain familiarity with gender identity development and consolidation.
2. Review key components of gender dysphoria diagnosis in pediatric and adult patients.
3. Introduction to the various gender affirming treatment options.
a. Focus on the role of the mental health treatment team
4. Highlights of notable updates from WPATH’s SOC 8.
a. Focus on the role of the mental health treatment team.
Gino Mortillaro, MD, General Psychiatry/Child and Adolescent Psychiatry, Assistant Chief of Service, Department of Psychiatry, Presence of Mind Physician Lead, Assistant Clinic Professor, Kaiser Permanente School of Medicine